Male breast cancer and sexual aspects research and analysis (MASARA study): preliminary results

To evaluate the impact of male breast cancer and its treatment on patient’s sexual function, including changes in sexual desire, performance, and satisfaction. To investigate changes in the body image experienced by male breast cancer patients and their perception in accessing healthcare in hospital facilities.

We administered three online questionnaires using Google Forms (Google LLC) to male breast cancer patients treated at our Institution from 2015 to 2023. The surveys were provided in Italian and distributed from March 1st to April 1st, 2024. A panel of one breast radiologist, one oncologist and one clinical psychologist designed a 22-item tailored survey to investigate imaging follow-up routine, sexual habits before and after treatment and perceived male breast cancer stigma. The International Index of Erectile Function and Italian version of the Body Image Scale were also administered. Replies to the three questionnaires were analyzed using descriptive statistical analysis.

Almost half of the patients completed the three questionnaires (33/70, 47%). The median age was 62 (IR 56–72). Only 27.8% were aware of male breast cancer prior to diagnosis. 86.1% (31/36) underwent regular breast imaging follow-up, with sexual activity declining during treatment. Endocrine treatment was reported by 63.9%. Discomfort was experienced, notably during interactions and communication about their condition. Erectile dysfunction was prevalent, with 18.2% reporting severe dysfunction. The average body image score was 9.1.

Our findings emphasize the importance of comprehensive care that attends to the full spectrum of emotional and social well-being beyond medical requirements in male breast cancer patients.